Journal IJCRT UGC-CARE, UGCCARE( ISSN: 2320-2882 ) | UGC Approved Journal | UGC Journal | UGC CARE Journal | UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, International Peer Reviewed Journal and Refereed Journal, ugc approved journal, UGC CARE, UGC CARE list, UGC CARE list of Journal, UGCCARE, care journal list, UGC-CARE list, New UGC-CARE Reference List, New ugc care journal list, Research Journal, Research Journal Publication, Research Paper, Low cost research journal, Free of cost paper publication in Research Journal, High impact factor journal, Journal, Research paper journal, UGC CARE journal, UGC CARE Journals, ugc care list of journal, ugc approved list, ugc approved list of journal, Follow ugc approved journal, UGC CARE Journal, ugc approved list of journal, ugc care journal, UGC CARE list, UGC-CARE, care journal, UGC-CARE list, Journal publication, ISSN approved, Research journal, research paper, research paper publication, research journal publication, high impact factor, free publication, index journal, publish paper, publish Research paper, low cost publication, ugc approved journal, UGC CARE, ugc approved list of journal, ugc care journal, UGC CARE list, UGCCARE, care journal, UGC-CARE list, New UGC-CARE Reference List, UGC CARE Journals, ugc care list of journal, ugc care list 2020, ugc care approved journal, ugc care list 2020, new ugc approved journal in 2020, ugc care list 2021, ugc approved journal in 2021, Scopus, web of Science.
How start New Journal & software Book & Thesis Publications
Submit Your Paper
Login to Author Home
Communication Guidelines

WhatsApp Contact
Click Here

  Published Paper Details:

  Paper Title

Analysis on focusing ACE 2 treatment strategies for new coronary pneumonia

  Authors

  Dr. R.Dinesh Kumar,  Dr.Pradeep Kumar,  M.Swapna,,  Ch.Swetha Bindu

  Keywords

coronavirus, transmembrane, ACE-2, pulmonary failure, down-regulation

  Abstract


Subsequently December 2019, the newfound Covid (2019-nCov) is produced an episode of pneumonia in Wuhan and produced incredible public concern. Covid attacks target cells by means of angiotensin-changing over compound 2 (ACE2). An exhaustive comprehension of the physiological qualities of the protein and the component of a progression of physiological and physiological fluctuations brought about by protein as the middle after the infection attacks the human body might assist by finding and clarify the comparing clinical marvel and afterward manage it as expected. Likewise, ACE2 is a possible Treatment goal. present article determination survey the attributes of the protein, target organ harm and treatment strategies. An essential for Covid contamination is its entrance hooked onhave cells. Here cycle, spike protein (S protein) perceives have cell receptors and incites combination of viral and cell films. The S protein of Wuhan Covid is like the S protein of SARS Covid (SARS-CoV) by organic investigation. It is likewise connectby the ACE2 protein particle on the outside of host cells concludedby S protein to contaminate Epithelial cells of the host. In this way, ACE2 particle is the vital atom for 2019-nCoV disease, and it might influence the cycle of 2019-nCoV contamination of human cells by official to ACE2 atom. Moreover, Shi Zhengli's group since Wuhan Virus Research Institute distributed a paper, revealing that ACE2 is a fundamental protein for 2019-nCoV contaminated cells. This article will audit the attributes of the protein, target organ harm, and restorative medications.

  IJCRT's Publication Details

  Unique Identification Number - IJCRTV020082

  Paper ID - 232690

  Page Number(s) - 505-510

  Pubished in - Volume 5 | Issue 4 | November 2017

  DOI (Digital Object Identifier) -   

  Publisher Name - IJCRT | www.ijcrt.org | ISSN : 2320-2882

  E-ISSN Number - 2320-2882

  Cite this article

  Dr. R.Dinesh Kumar,  Dr.Pradeep Kumar,  M.Swapna,,  Ch.Swetha Bindu,   "Analysis on focusing ACE 2 treatment strategies for new coronary pneumonia", International Journal of Creative Research Thoughts (IJCRT), ISSN:2320-2882, Volume.5, Issue 4, pp.505-510, November 2017, Available at :http://www.ijcrt.org/papers/IJCRTV020082.pdf

  Share this article

  Article Preview

  Indexing Partners

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
Call For Paper July 2024
Indexing Partner
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
ISSN and 7.97 Impact Factor Details


ISSN
ISSN
ISSN: 2320-2882
Impact Factor: 7.97 and ISSN APPROVED
Journal Starting Year (ESTD) : 2013
ISSN
DOI Details

Providing A Free digital object identifier by DOI.one How to get DOI?
For Reviewer /Referral (RMS) Earn 500 per paper
Our Social Link
Open Access
This material is Open Knowledge
This material is Open Data
This material is Open Content
Indexing Partner

Scholarly open access journals, Peer-reviewed, and Refereed Journals, Impact factor 7.97 (Calculate by google scholar and Semantic Scholar | AI-Powered Research Tool) , Multidisciplinary, Monthly, Indexing in all major database & Metadata, Citation Generator, Digital Object Identifier(DOI)

indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer
indexer